Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2026-05-18 @ 5:51 AM
Study NCT ID:
NCT04957758
Status:
COMPLETED
Last Update Posted:
2024-05-07
First Post:
2021-06-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2 Clinical Trial to Evaluate OC-01 Nasal Spray in Subjects With Neurotrophic Keratopathy
Sponsor:
Oyster Point Pharma, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
OPP-102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None